Philips enters into collaboration with Janssen to develop new handheld blood test

27-Mar-2015 - Royal Philips announced that it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V.. The collaboration aims to develop a new handheld blood test to provide doctors with a novel tool to improve the care of patients with neuropsychiatric disorders.The collaboration ...

Cenix BioScience Signs Collaboration and Technology License Agreement for In Vivo siRNA Delivery

06-May-2011 - Cenix BioScience GmbH announced that, together with its new subsidiary, Cenix BioScience Belgium bvba, it has signed a Collaboration and Technology License Agreement with Janssen Research & Development, a division of Janssen Pharmaceutica NV, to improve the in vivo applicability of siRNA-based ...

Intana Announces Agreement to Provide Proprietary Spectroscopy Technology

15-Jul-2010 - Intana Bioscience GmbH announced that it has entered an agreement with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V., Beerse, Belgium. Under the agreement, Intana will provide its proprietary Fluorescent Cross Correlation Spectroscopy (FCCS) ...

Intana Announces Agreement to Provide Proprietary Spectroscopy Technology

07-Jul-2010 - Intana Bioscience GmbH announced that it has entered an agreement with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V., Beerse, Belgium. Under the agreement, Intana will provide its proprietary Fluorescent Cross Correlation Spectroscopy (FCCS) ...

PamGene Platform Adopted for Kinase Drug R&D Program

Collaboration with Johnson & Johnson Pharmaceutical Research & Development

13-Mar-2006 - PamGene International BV and Johnson & Johnson Pharmaceutical Research & Development (J&JPRD), a division of Janssen Pharmaceutica NV have announced significant progress in their kinase profiling collaboration. After extensive evaluation, PamGene's microarray-based biochemical kinase activity ...